性感染症（STI）の世界市場レポート 2025年

性感染症（STI）の市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）12.0％で1,133億8,000万米ドルに成長します。予測期間の成長は、新たなsti株、ワクチン接種の取り組み、遠隔医療と在宅検査、性的健康の公平性に起因しています。予測期間の主な動向には、抗菌薬耐性の上昇、曝露前予防（pre-exposure prophylaxis：prep）、stiの自己管理、性教育の強化などがあります。

政府主導のイニシアチブは、性感染症（STI）市場の成長を促進する上で極めて重要な役割を果たしています。こうした政府の取り組みは、STIに対する認識を高めることを目的としたさまざまなプログラムや政策を包含しており、市場拡大の原動力になると期待されています。これらのプログラムはSTIに関連する課題に対処するために特別に設計されており、一般的にはSTIの認知度を高めるための公教育キャンペーンに資金を割り当てることが含まれます。さらに、政府の取り組みには、特定のSTIを予防するワクチンの開発や、無料または低料金の検診・検査サービスの提供が含まれることもあります。特筆すべき例として、2023年4月にスプリングフィールド-グリーン郡保健所がミズーリ州保健高齢者サービス局（Missouri Department of Health and Senior Services：Missouri DHSS）と共同で開始した疾病介入専門家（Disease Intervention Specialist：DIS）プログラムがあります。このプログラムは、梅毒とHIVを中心に、増加する性感染症の対策に重点を置いています。DISプログラムでは、これらの感染症で陽性と判定された人に専門家が積極的に働きかけ、治療へのアクセスを促進し、感染の可能性に対する認識を高めるために接触者追跡を確実に行う。そのため、政府のイニシアチブは性感染症（STI）市場の成長促進要因になると予想されます。

無防備な性交渉の蔓延は、性感染症（STI）市場の成長を促進すると予想されます。無防備セックスの増加とは、コンドームなどの保護具を使用せずに性行為に及ぶことを指し、性感染症の蔓延につながる可能性があります。例えば、2024年8月に世界保健機関（WHO）が報告したところによると、2022年、性的に活発な青少年が直近の性交でコンドームを使用した割合は減少し、コンドームの使用を報告した男子は61％、女子は57％で、それぞれ70％、63％から減少しました。このように、無防備なセックスの増加がSTI市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界性感染症（STI） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の性感染症（STI）市場：成長率分析
• 世界の性感染症（STI）市場の実績：規模と成長, 2019-2024
• 世界の性感染症（STI）市場の予測：規模と成長, 2024-2029, 2034F
• 世界性感染症（STI）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の性感染症（STI）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト免疫不全ウイルス（HIV）
• ヒトパピローマウイルス（HPV）
• 淋病
• 梅毒
• その他のタイプ
• 世界の性感染症（STI）市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 抗ウィルス薬
• 世界の性感染症（STI）市場テスト場所別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床検査
• ポイントオブケア（POC）検査
• 世界の性感染症（STI）市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界の性感染症（STI）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• ホームケア
• その他のエンドユーザー
• 世界の性感染症（STI）市場、ヒト免疫不全ウイルス（HIV）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• HIVタイプ1
• HIVタイプ2
• 世界の性感染症（STI）市場、ヒトパピローマウイルス（HPV）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低リスクHPV
• 高リスクHPV
• 世界の性感染症（STI）市場、淋病の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単純淋病
• 複雑な淋病
• 世界の性感染症（STI）市場梅毒のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一次梅毒
• 二次梅毒
• 第三期梅毒
• 世界の性感染症（STI）市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クラミジア
• 単純ヘルペスウイルス（HSV）
• B型肝炎
• C型肝炎
• トリコモナス症

第7章 地域別・国別分析

• 世界の性感染症（STI）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の性感染症（STI）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 性感染症（STI）市場：競合情勢
• 性感染症（STI）市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holdings AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb
• Astra Zeneca Pharmaceuticals LP
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Gilead Sciences Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Co. Ltd.
• Hetero Drugs Ltd.
• Eisai Co. Ltd.
• Boehringer Ingelheim Group
• Sun Pharmaceutical Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 性感染症（STI）市場2029：新たな機会を提供する国
• 性感染症（STI）市場2029：新たな機会を提供するセグメント
• 性感染症（STI）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sexually transmitted infections (STIs), also referred to as sexually transmitted diseases (STDs), are a group of illnesses caused by viruses, bacteria, and parasites that are transmitted from one individual to another through sexual contact. These infections can be spread through vaginal, anal, and oral sexual intercourse, as well as through skin-to-skin contact.

The primary types of sexually transmitted infections (STIs) include human immunodeficiency virus (HIV), human papillomavirus (HPV), gonorrhea, syphilis, and others. Human Immunodeficiency Virus (HIV) is a virus that affects the body's immune system by targeting a specific type of white blood cell that plays a crucial role in resisting infections. Various treatments, including antibiotics and antivirals, are available, with testing conducted in diverse settings such as laboratory testing and point-of-care (POC) testing. These treatments are administered via oral, parenteral, and other routes and are commonly provided in hospitals, specialty clinics, homecare, and other healthcare settings.

The sexually transmitted infections (STIs) market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted infections (STIs) market statistics, including sexually transmitted infections (STIs) industry global market size, regional shares, competitors with a sexually transmitted infections (STIs) market share, detailed sexually transmitted infections (STIs) market segments, market trends and opportunities and any further data you may need to thrive in the sexually transmitted infections (STIs) industry. This sexually transmitted infections (STIs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted infections (STIs) market size has grown rapidly in recent years. It will grow from $63.69 billion in 2024 to $71.93 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to behavioral factors, education and awareness, healthcare access, antibiotic development.

The sexually transmitted infections (STIs) market size is expected to see rapid growth in the next few years. It will grow to $113.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to emerging sti strains, vaccination initiatives, telemedicine and at-home testing, sexual health equity. Major trends in the forecast period include rise of antimicrobial resistance, pre-exposure prophylaxis (prep), sti self-management, enhanced sexual education.

Government-driven initiatives are playing a pivotal role in fueling the growth of the sexually transmitted infections (STIs) market. These government initiatives encompass a range of programs and policies aimed at raising awareness of STIs and are expected to be a driving force behind the market's expansion. These programs are specifically designed to address the challenges associated with STIs and typically involve allocating funds for public education campaigns to increase STI awareness. Additionally, government initiatives may include the development of vaccines to prevent certain STIs and the provision of free or low-cost screening and testing services. A notable example is the Disease Intervention Specialist (DIS) program launched by the Springfield-Greene County Health department in April 2023, in collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS). This program focuses on countering the increasing prevalence of sexually transmitted infections, with a primary emphasis on syphilis and HIV. The DIS program involves experts who proactively reach out to individuals who have tested positive for these infections, facilitating access to treatment and ensuring contact tracing to raise awareness about potential infection. Therefore, government initiatives are expected to be a driving factor for the growth of the sexually transmitted infections (STIs) market.

The growing prevalence of unprotected sex is expected to drive the growth of the sexually transmitted infections (STIs) market. The increasing practice of unprotected sex refers to engaging in sexual activities without using protection, such as condoms, which can lead to the spread of sexually transmitted infections. For example, in August 2024, the World Health Organization reported that in 2022, the percentage of sexually active adolescents using condoms during their most recent intercourse decreased, with 61% of boys and 57% of girls reporting condom use, down from 70% and 63%, respectively. Thus, the rise in unprotected sex is contributing to the expansion of the STIs market.

Major companies within the sexually transmitted infections (STIs) market are pioneering innovative products that incorporate fluorescent PCR technology to gain a competitive edge in the market. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique used to detect and quantify specific DNA sequences in a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymerase chain reaction (PCR) kits including the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits offer a comprehensive PCR solution for the early diagnosis of sexually transmitted infections, which affect a significant population. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that utilizes fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.

In February 2023, Caraway Health, a US-based provider of digital healthcare services for Generation Z, entered into a partnership with Ash Wellness Inc. The collaboration addresses the surge in sexually transmitted infections (STIs) on university campuses among Generation Z. This partnership equips Generation Z with the tools necessary to prioritize their sexual well-being on their own terms. Ash Wellness Inc. is a US-based provider of remote diagnostic solutions, including home HIV and STI testing.

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted infections (STIs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted infections (STIs) market consists of revenues earned by entities by providing services such as treatment, testing, awareness programs and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infections (STIs) market also includes the sales of treatments such as testing kits, vaccines and medication. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Infections (STIs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted infections (stis) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted infections (stis) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sexually transmitted infections (stis) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
• 2) By Treatment: Antibiotics; Antiviral
• 3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
• 4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Human Immunodeficiency Virus (HIV): HIV Type 1; HIV Type 2
• 2) By Human Papilloma Virus (HPV): Low-Risk HPV; High-Risk HPV
• 3) By Gonorrhea: Uncomplicated Gonorrhea; Complicated Gonorrhea
• 4) By Syphilis: Primary Syphilis; Secondary Syphilis; Tertiary Syphilis
• 5) By Other Types: Chlamydia; Herpes Simplex Virus (HSV); Hepatitis B; Hepatitis C; Trichomoniasis
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holdings AG; Merck & Co Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Infections (STIs) Market Characteristics

3. Sexually Transmitted Infections (STIs) Market Trends And Strategies

4. Sexually Transmitted Infections (STIs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sexually Transmitted Infections (STIs) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sexually Transmitted Infections (STIs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sexually Transmitted Infections (STIs) Market Growth Rate Analysis
• 5.4. Global Sexually Transmitted Infections (STIs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sexually Transmitted Infections (STIs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sexually Transmitted Infections (STIs) Total Addressable Market (TAM)

6. Sexually Transmitted Infections (STIs) Market Segmentation

• 6.1. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Immunodeficiency Virus (HIV)
• Human Papilloma Virus (HPV)
• Gonorrhea
• Syphilis
• Other Types
• 6.2. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antiviral
• 6.3. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing
• Point-Of-Care (POC) Testing
• 6.4. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Route Of Administration
• 6.5. Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HIV Type 1
• HIV Type 2
• 6.7. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Risk HPV
• High-Risk HPV
• 6.8. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Uncomplicated Gonorrhea
• Complicated Gonorrhea
• 6.9. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Syphilis
• Secondary Syphilis
• Tertiary Syphilis
• 6.10. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chlamydia
• Herpes Simplex Virus (HSV)
• Hepatitis B
• Hepatitis C
• Trichomoniasis

7. Sexually Transmitted Infections (STIs) Market Regional And Country Analysis

• 7.1. Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Infections (STIs) Market

• 8.1. Asia-Pacific Sexually Transmitted Infections (STIs) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Infections (STIs) Market

• 9.1. China Sexually Transmitted Infections (STIs) Market Overview
• 9.2. China Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Infections (STIs) Market

• 10.1. India Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Infections (STIs) Market

• 11.1. Japan Sexually Transmitted Infections (STIs) Market Overview
• 11.2. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Infections (STIs) Market

• 12.1. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Infections (STIs) Market

• 13.1. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Infections (STIs) Market

• 14.1. South Korea Sexually Transmitted Infections (STIs) Market Overview
• 14.2. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Infections (STIs) Market

• 15.1. Western Europe Sexually Transmitted Infections (STIs) Market Overview
• 15.2. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Infections (STIs) Market

• 16.1. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Infections (STIs) Market

• 17.1. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Infections (STIs) Market

• 18.1. France Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Infections (STIs) Market

• 19.1. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Infections (STIs) Market

• 20.1. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Infections (STIs) Market

• 21.1. Eastern Europe Sexually Transmitted Infections (STIs) Market Overview
• 21.2. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Infections (STIs) Market

• 22.1. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Infections (STIs) Market

• 23.1. North America Sexually Transmitted Infections (STIs) Market Overview
• 23.2. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Infections (STIs) Market

• 24.1. USA Sexually Transmitted Infections (STIs) Market Overview
• 24.2. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Infections (STIs) Market

• 25.1. Canada Sexually Transmitted Infections (STIs) Market Overview
• 25.2. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Infections (STIs) Market

• 26.1. South America Sexually Transmitted Infections (STIs) Market Overview
• 26.2. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Infections (STIs) Market

• 27.1. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Infections (STIs) Market

• 28.1. Middle East Sexually Transmitted Infections (STIs) Market Overview
• 28.2. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Infections (STIs) Market

• 29.1. Africa Sexually Transmitted Infections (STIs) Market Overview
• 29.2. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Infections (STIs) Market Competitive Landscape And Company Profiles

• 30.1. Sexually Transmitted Infections (STIs) Market Competitive Landscape
• 30.2. Sexually Transmitted Infections (STIs) Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holdings AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Infections (STIs) Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb
• 31.4. Astra Zeneca Pharmaceuticals LP
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Gilead Sciences Inc.
• 31.8. Viatris Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Astellas Pharma Inc.
• 31.11. Daiichi Sankyo Co. Ltd.
• 31.12. Hetero Drugs Ltd.
• 31.13. Eisai Co. Ltd.
• 31.14. Boehringer Ingelheim Group
• 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Sexually Transmitted Infections (STIs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market

34. Recent Developments In The Sexually Transmitted Infections (STIs) Market

35. Sexually Transmitted Infections (STIs) Market High Potential Countries, Segments and Strategies

• 35.1 Sexually Transmitted Infections (STIs) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sexually Transmitted Infections (STIs) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sexually Transmitted Infections (STIs) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer